Research on the innate immune system of the cornea
Research on the innate immune system of the cornea
批准号:
14571674
负责人:
KUMAGAI Naoki
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003
中文摘要
为了阐明角膜细胞在角膜先天免疫系统中的作用,我们揭示了以下事实:1)培养的人角膜成纤维细胞表达toll样受体(TLR)-4和分化簇(CD) 14,它们是LPS受体的组成部分。这些细胞还表达MD-2蛋白,这是LPS受体在细胞膜上合理分布所必需的。2)大肠杆菌、绿绿p.a rubginosa和S Minnesota来源的LPS增强了培养的人角膜成纤维细胞IL-8、MCP-1和ICAM-1的表达。这种效应是时间和剂量依赖的。LPS对这些蛋白表达的影响是E.coli> s.m nminnesota >> p.a ulugnosa3)人泪液中确实含有LBP和sCD14。这些lps相关蛋白的浓度分别约为1微克/毫升和400纳克/毫升。这些脂多糖相关蛋白在泪液中的浓度低于在相同设置下测量的血清中的浓度。泪液中这些脂多糖相关蛋白的浓度与血清之间没有明显的关系。4)添加LBP或sCD14诱导培养的人角膜成纤维细胞IL-8释放和ICAM-1表达呈剂量依赖性增加。血清中脂多糖相关蛋白的刺激作用比泪液中脂多糖的刺激作用更明显。将脂多糖注射到兔角膜基质中可引起角膜溃疡和角膜混浊。这些角膜损伤是短暂的,角膜会自行愈合,留下角膜瘢痕。组织学上,中性粒细胞浸润到角膜基质中。我们的研究表明,角膜细胞,特别是角膜成纤维细胞,在外眼的先天免疫系统中起作用。这些细胞感知LPS的存在,这是革兰氏阴性细菌细胞壁的常见结构,并表达中性粒细胞活化和趋化因子如ICAM-1和il - 8lps相关蛋白如LBP或sCD14,增强角膜细胞对LPS的感知
英文摘要
In order to clarify the roles of corneal cells in innate immune system of the cornea, we revealed the following facts1) Cultured human corneal fibroblasts express toll-like receptor (TLR)-4 and cluster of differentiation (CD) 14, which are the components of LPS receptors. These cells also express MD-2 protein, which is necessary for the proper distribution of LPS receptors on the cell membrane2) LPS derived from E Coli, P.aerubginosa and S Minnesota enhanced the expression of IL-8, MCP-1 and ICAM-1 by cultured human corneal fibroblast. This effect was time and dose-dependent. The effect of LPS on the expression on these proteins are E.coli> S.Minnesota>> P.aeruglnosa3) Human tear fluids did contain LBP and sCD14. The concentrations of these LPS-related proteins were about 1 micro gram 1 ml and 400 nano gram /ml, respectively. The concentrations of these LPS-related proteins were lower in the tear fluids than that in the serum measured with a same settings. There were no relationships b … More etween the concentration of these LPS-related proteins in the tear fluids and the serum4) Addition of LBP or sCD14 induced a dose dependent increase of IL-8 release and ICAM-1 expression by cultured human corneal fibroblasts. The stimulatory effect of these LPS-related proteins axe more pronounced at a concentration of the serum than that of the tear fluids5) Injection of LPS into a rabbit corneal stroma induced a corneal ulcer and corneal opacity. These corneal lesions are transient the cornea is healed spontaneously leaving corneal scarring. Histologically, infiltration of neutrophils is observed in to the corneal stromaOur study shows that the cells of the cornea, especially the corneal fibroblasts, play a role in the innate immune system of the outer eye. These cells perceive the presence of LPS, which is a common structure of Gram negative bacterial cell walls, and express neutrophils activation and chemotactic factors such as ICAM-1 and IL-8LPS-related proteins such as LBP or sCD14 enhance the perception of LPS by corneal cells Less
期刊论文(31)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Naoki Kumagai et al.: "Expression of functional ICAM-1 on cultured human keratocytes induced by tumor necrosis factor-α"Japanese Journal of Ophthalmology. 47. 134-141 (2003)
Naoki Kumagai 等人:“肿瘤坏死因子-α 诱导的培养人角膜细胞上功能性 ICAM-1 的表达”日本眼科杂志 47. 134-141 (2003)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ken Fukuda et al.: "Differential expression of thymus and activation-regulated chemokine (CCL17) and macrophage-derived chemokine (CCL22) by human fibroblasts from cornea, skin, and lung"The Journal of Allergy and Clinical Immunology. 111-3. 520-526 (2003
Ken Fukuda 等人:“来自角膜、皮肤和肺的人成纤维细胞胸腺和活化调节趋化因子 (CCL17) 和巨噬细胞衍生趋化因子 (CCL22) 的差异表达”《过敏与临床免疫学杂志》。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Qin Li et al.: "Enhancement by neutrophils of collagen degradation by corneal fibroblasts"Journal of Leukocyte Biology. 74-3. 412-419 (2003)
李勤等人:“中性粒细胞增强角膜成纤维细胞对胶原蛋白的降解”,白细胞生物学杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ying Lu et al.: "Inhibition by triptolide of IL-1-induced collagen degradation by corneal fibroblasts"Investigative Ophthalmology and Visual Science. 44. 5082-5088 (2003)
Ying Lu 等人:“雷公藤内酯醇对角膜成纤维细胞 IL-1 诱导的胶原蛋白降解的抑制”研究眼科和视觉科学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Youichiro Fujitsu et al.: "IL-4-induced cell proliferation and production of extracellular matrix proteins in human conjunctival fibroblasts"Experimental Eye Research. 76-1. 107-114 (2003)
Youichiro Fujitsu等人:“人结膜成纤维细胞中IL-4诱导的细胞增殖和细胞外基质蛋白的产生”实验眼科研究。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 22 条
Role of corneal-conjunctival interaction on the pathogenesis of allergic conjunctivitis
-
批准号:17591837
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2005
-
负责人:KUMAGAI Naoki
-
依托单位:
Role for corneal fibroblasts in the pathogenesis of allergic conjunctival diseases
-
批准号:11671741
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:1999
-
负责人:KUMAGAI Naoki
-
依托单位:
JOINT STUDY ON DEVELOPMENT OF NEW INERCALATION ELECTRODES
-
批准号:11695036
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$3.46万
-
财政年份:1999
-
负责人:KUMAGAI Naoki
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于肠道菌群探讨健脾化痰方通过调节LPS/NF-κB信号通路改善多囊卵巢综合征的机制研究
-
批准号:2026JJ80146
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:余曦明
-
依托单位:
基于4D Flow MRI 技术联合HA/cRGD-GD-LPs对比剂增强扫描诊断肝纤维化分期的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:李刚静
-
依托单位:
基于肠道微生态的他莫昔芬-LPS-OTUD6A-HDAC3轴诱导乳腺癌内分泌治疗耐药的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:祝琦
-
依托单位:
基于肠道菌群介导的LPS/TLR4/NF-κB信号通路探讨针灸对脑缺血再灌注损伤大鼠的抑炎作用机制
-
批准号:2025JJ90298
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:赖碧玉
-
依托单位:
肺炎克雷伯菌WaaLCPS连接酶相关的CPS-LPS合成通路及致病机制的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:何平
-
依托单位:
半夏白术天麻汤通过抑制肠源性LPS/NF-κB通路减少NETs形成抗高血压血管内皮损伤的机制研究
-
批准号:KLY25H270034
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:李波
-
依托单位:
基于“肠-肾轴”研究金花葵非药用部位经菌群-代谢物-TLR4/NF-κB调控LPS炎症小鼠的作用机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:廖光琴
-
依托单位:
噬菌体抑制LPS-TLR4-NF-κB信号通路纠
正菌群失衡在子痫前期发病中的机制研
究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:吕莉娟
-
依托单位:
热灭活L.hilgardii通过Betaine募集MDSCs缓解LPS诱导急性肝损伤的机制研究
-
批准号:QN25H020022
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:李学慧
-
依托单位:
肠杆菌Klebsiella pneumoniae衍生的LPS通过肝脏HADHA-K353乙酰化修饰加剧MASLD合并T2DM疾病进程的机制研究
-
批准号:2025JJ60788
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:罗武
-
依托单位: